Sandra Percell

Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis

Edward Abraham, Konrad Reinhart, Steven M. Opal et al. · JAMA · 2003 · 957 citations

Medicine, Pharmacology, Pharmacotherapy +15

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Edward Abraham, Konrad Reinhart, Petr Svoboda et al. · Critical Care Medicine · 2001 · 253 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

Robert F. Pass, Anne‐Marie Duliège, Suresh B. Boppana et al. · The Journal of Infectious Diseases · 1999 · 252 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine

Sharon E. Frey, Christopher Harrison, Robert F. Pass et al. · The Journal of Infectious Diseases · 1999 · 106 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study

Kirsten P. Perrett, Jodie McVernon, Peter Richmond et al. · Vaccine · 2015 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16